
Lora E. Barnhart Driscoll
Supervisory Patent Examiner (ID: 10285, Phone: (571)272-1928 , Office: P/1600 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1653, 1651, 3991, 1600 |
| Total Applications | 786 |
| Issued Applications | 186 |
| Pending Applications | 142 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10062779
[patent_doc_number] => 09101608
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-08-11
[patent_title] => 'Preservation of the biological activity of undenatured type II collagen'
[patent_app_type] => utility
[patent_app_number] => 13/986572
[patent_app_country] => US
[patent_app_date] => 2013-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12491
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/986572 | Preservation of the biological activity of undenatured type II collagen | May 14, 2013 | Issued |
| 13/986569 | Preservation of the biological activity of undenatured type II collagen | May 14, 2013 | Abandoned |
Array
(
[id] => 9042617
[patent_doc_number] => 20130245255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'HETEROCYCLIC COMPOUNDS AND EXPANSION AGENTS FOR HEMATOPOIETIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/875387
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36392
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875387
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875387 | Heterocyclic compounds and expansion agents for hematopoietic stem cells | May 1, 2013 | Issued |
Array
(
[id] => 9120828
[patent_doc_number] => 20130287750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'METHOD OF SELECTING STEM CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/863115
[patent_app_country] => US
[patent_app_date] => 2013-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21487
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863115
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/863115 | METHOD OF SELECTING STEM CELLS AND USES THEREOF | Apr 14, 2013 | Abandoned |
| 13/848587 | DEFINED SYSTEMS FOR EPITHELIAL CELL CULTURE AND USE THEREOF | Mar 20, 2013 | Abandoned |
Array
(
[id] => 9908940
[patent_doc_number] => 20150064141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'REGENERATIVE SERA CELLS AND MESENCHYMAL STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/390738
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30060
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390738
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390738 | REGENERATIVE SERA CELLS AND MESENCHYMAL STEM CELLS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 10090439
[patent_doc_number] => 09127252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Multipotent stem cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/798720
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 27
[patent_no_of_words] => 24871
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13798720
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/798720 | Multipotent stem cells and uses thereof | Mar 12, 2013 | Issued |
Array
(
[id] => 9041630
[patent_doc_number] => 20130244268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'CANCER STEM CELLS EXPRESSING ABCG2'
[patent_app_type] => utility
[patent_app_number] => 13/782350
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18523
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782350
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782350 | CANCER STEM CELLS EXPRESSING ABCG2 | Feb 28, 2013 | Abandoned |
Array
(
[id] => 8891603
[patent_doc_number] => 20130164787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/761078
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 45342
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761078
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/761078 | Cell compositions derived from dedifferentiated reprogrammed cells | Feb 5, 2013 | Issued |
Array
(
[id] => 9977108
[patent_doc_number] => 09023416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Preservation of the biological activity of undenatured type II collagen'
[patent_app_type] => utility
[patent_app_number] => 13/694971
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12489
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13694971
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/694971 | Preservation of the biological activity of undenatured type II collagen | Jan 22, 2013 | Issued |
Array
(
[id] => 10181641
[patent_doc_number] => 09211306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose'
[patent_app_type] => utility
[patent_app_number] => 13/738479
[patent_app_country] => US
[patent_app_date] => 2013-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11007
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13738479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/738479 | Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose | Jan 9, 2013 | Issued |
Array
(
[id] => 8950028
[patent_doc_number] => 20130195808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'MESENCHYMAL STEM CELL AND A METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/733008
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6606
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733008
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/733008 | MESENCHYMAL STEM CELL AND A METHOD OF USE THEREOF | Jan 1, 2013 | Abandoned |
Array
(
[id] => 10966940
[patent_doc_number] => 20140369972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'ENHANCED STEM CELL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/362386
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32704
[patent_no_of_claims] => 162
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/362386 | Enhanced stem cell composition | Nov 28, 2012 | Issued |
Array
(
[id] => 9003105
[patent_doc_number] => 20130224230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'THERAPEUTIC USES OF GLANDULAR KALLIKREIN'
[patent_app_type] => utility
[patent_app_number] => 13/666669
[patent_app_country] => US
[patent_app_date] => 2012-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15583
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666669
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/666669 | THERAPEUTIC USES OF GLANDULAR KALLIKREIN | Oct 31, 2012 | Abandoned |
Array
(
[id] => 8865644
[patent_doc_number] => 20130149347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'ISOLATED RENAL CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/661668
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 108
[patent_figures_cnt] => 108
[patent_no_of_words] => 68087
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13661668
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/661668 | Isolated renal cells and uses thereof | Oct 25, 2012 | Issued |
Array
(
[id] => 8707512
[patent_doc_number] => 20130064801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Cellular Compositions and Methods of Making and Using Them'
[patent_app_type] => utility
[patent_app_number] => 13/650596
[patent_app_country] => US
[patent_app_date] => 2012-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24595
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13650596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/650596 | Cellular Compositions and Methods of Making and Using Them | Oct 11, 2012 | Abandoned |
Array
(
[id] => 9440294
[patent_doc_number] => 08709402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Amnion-derived cells, methods of making and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/644042
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 40578
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/644042 | Amnion-derived cells, methods of making and uses thereof | Oct 2, 2012 | Issued |
Array
(
[id] => 10850503
[patent_doc_number] => 08877181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Amnion-derived cells, methods of making and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/644026
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 40591
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644026
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/644026 | Amnion-derived cells, methods of making and uses thereof | Oct 2, 2012 | Issued |
Array
(
[id] => 8814152
[patent_doc_number] => 20130115197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Amnion-derived cell compositions, methods of making and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/644052
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 40563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/644052 | Amnion-derived cell compositions, methods of making and uses thereof | Oct 2, 2012 | Issued |
Array
(
[id] => 8779700
[patent_doc_number] => 20130101675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Cross-Linked Non-Demineralized Collagenous Biomaterial'
[patent_app_type] => utility
[patent_app_number] => 13/624276
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8647
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624276
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/624276 | Cross-Linked Non-Demineralized Collagenous Biomaterial | Sep 20, 2012 | Abandoned |